Newsletter 466
Critical Care Reviews Newsletter
Newsletter 474 | January 11th 2021
Welcome to the 474th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days. It's a small newsletter as it's the week before the annual meeting, and I have limited time to put this together.
The highlights of this week's edition are four randomised controlled trials: firstly, the preprint of the REMAP-CAP IL-6 receptor anatgonists domain; secondly, another tocilizumab trial, this time in a more general population...